Jose Muñoz-Langa

TL;DR: Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian patients with non-small-cell lung cancer (NSCLC) with activating EGFR mutations as discussed by the authors.

TL;DR: In this paper , a group of experts met to discuss and provide an up-to-date review of the current understanding of the biological mechanisms through which tumors spread to the bone and describe the imaging methods available to diagnose bone metastasis and monitor their response to oncological treatment, focusing on patients with breast and prostate cancer.

TL;DR: Iron parameters are not commonly measured in newly diagnosed cancer patients and a correct evaluation and early management of ID could reduce the incidence of treatment-related anaemia in cancer patients.

TL;DR: These results suggest an appropriate and rational use of erythropoiesis-stimulating agents in the treatment of chemotherapy-associated anemia in lung cancer patients.

TL;DR: It is found that the most frequent manifestations of lipedema were bilateral involvement, unaffected feet, pain, easy bruising, vascular spiders, and disproportion between the upper and lower parts of the body.